Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

Genome Research

Volumn 24, Issue 2, 2014, Pages 212-226

  Ferreira, Pedro G ^a,b,i   Jares, Pedro ^c   Rico, Daniel ^d   Gómez López, Gonzalo ^d   Martínez Trillos, Alejandra ^c   Villamor, Neus ^c   Ecker, Simone ^d   González Pérez, Abel ^b   Knowles, David G ^a,b   Monlong, Jean ^a,b   Johnson, Rory ^a,b   Quesada, Victor ^e   Djebali, Sarah ^a,b   Papasaikas, Panagiotis ^a,b   López Guerra, Mónica ^c   Colomer, Dolors ^c   Royo, Cristina ^c   Cazorla, Maite ^c   Pinyol, Magda ^c   Clot, Guillem ^c   Aymerich, Marta ^c   Rozman, Maria ^c   Kulis, Marta ^c   Tamborero, David ^b   Gouin, Anaïs ^a,b   Blanc, Julie ^f   Gut, Marta ^f   Gut, Ivo ^f   Puente, Xose S ^e   Pisano, David G ^d   Martin Subero, José Ignacio ^c   López Bigas, Nuria ^b,g   López Guillermo, Armando ^h   Valencia, Alfonso ^d   López Otín, Carlos ^e   Campo, Elías ^c   Guigó, Roderic ^a,b   more..

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

^f PNT PCB   (Spain)

^g INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^h INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

ⁱ UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; TRANSCRIPTOME;

ARTICLE; B LYMPHOCYTE; CANCER PATIENT; CELL SUBPOPULATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA MICROARRAY; EXOME; GENE MUTATION; GENE PRODUCT; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN HEAVY CHAIN GENE; PRIORITY JOURNAL; PSEUDOGENE; RIBOSOME; RNA SEQUENCE; RNA SPLICING; SPLICEOSOME; TRANSPOSON;

AGED; B-LYMPHOCYTES; BASE SEQUENCE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; MUTATION; RIBOSOMES; SPLICEOSOMES;

EID: 84893699492     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.152132.112     Document Type: Article

References (67)

1. Anczukow O, Rosenberg AZ, Akerman M, Das S, Zhan L, Karni R, Muthuswamy SK, Krainer AR. 2012. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 19: 220-228.
2. Antonov AV. 2011. BioProfiling.de: Analytical web portal for highthroughput cell biology. Nucleic Acids Res 39: W323-W327.
3. Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, Maguire J, Johnson LA, Robinson J, Verhaak RG, Sougnez C, et al. 2010. Integrative analysis of the melanoma transcriptome. Genome Res 20: 413-427.
4. Buchner M, Fuchs S, Prinz G, Pfeifer D, Bartholome K, Burger M, Chevalier N, Vallat L, Timmer J, Gribben JG, et al. 2009. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. Cancer Res 69: 5424-5432.
5. Burger JA, Gandhi V. 2009. The lymphatic tissue microenvironments in chronic lymphocytic leukemia: In vitro models and the significance of CD40-CD154 interactions. Blood 114: 2560-2561, author reply 2561-2562.
6. Chuang H, Rassenti L, Salcedo M, Licon K, Kohlmann A, Haferlach T, Foa R, Ideker T, Kipps T. 2012. Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression. Blood 120: 2639-2649.
7. Clauset A, Newman ME, Moore C. 2004. Finding community structure in very large networks. Phys Rev E 70: 066111.
8. Corrionero A, Minana B, Valcarcel J. 2011. Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes Dev 25: 445-459.
9. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, Lovci MT, Morell M, O'Shea KS, Moran JV, Gage FH. 2009. L1 retrotransposition in human neural progenitor cells. Nature 460: 1127-1131.
10. Cox D. 1972. Regression models and life tables. J R Stat Soc Series B Stat Methodol 34: 187-220.
11. Djebali S, Davis C, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, LinW, Schlesinger F, et al. 2012. Landscape of transcription in human cells. Nature 489: 101-108.
12. Duhren-von Minden M, U? belhart R, Schneider D, Wossning T, Bach M, Buchner M, Hofmann D, Surova E, Follo M, Kohler F, et al. 2012. Chronic lymphocytic leukaemia is driven by antigen-independent cellautonomous signalling. Nature 489: 309-312.
13. Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J, Grunn A, Fangazio M, Capello D, Monti S, et al. 2011. Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation. J Exp Med 208: 1389-1401.
14. Fabris S, Mosca L, Todoerti K, Cutrona G, Lionetti M, Intini D, Matis S, Colombo M, Agnelli L, Gentile M, et al. 2008. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 47: 781-793.
15. Friedman J, Hastie T, Tibshirani R. 2008. Sparse inverse covariance estimation with the graphical lasso. Biostatistics 9: 432-441.
16. Friedman DR,Weinberg JB, Barry WT, Goodman BK, Volkheimer AD, Bond KM, Chen Y, Jiang N, Moore JO, Gockerman JP, et al. 2009. A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clin Cancer Res 15: 6947-6955.
17. Gonzalez-Porta M, Calvo M, Sammeth M, Guigo R. 2011. Estimation of alternative splicing variability in human populations. Genome Res 22: 528-538.
18. Guarini A, Chiaretti S, Tavolaro S, Maggio R, Peragine N, Citarella F, Ricciardi MR, Santangelo S, Marinelli M, De Propris MS, et al. 2008. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. Blood 112: 782-792.
19. Gundem G, Lopez-Bigas N. 2012. Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types. Genome Med 4: 28.
20. Harrow J, Denoeud F, Frankish A, Reymond A, Chen CK, Chrast J, Lagarde J, Gilbert JG, Storey R, Swarbreck D et al. 2006. GENCODE: Producing a reference annotation for ENCODE. Genome Biol 7: S4.1-S4.9.
21. Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B, Gibellini F, Njuguna N, Lee E, Stennett L, et al. 2011. The lymph node microenvironment promotes B-cell receptor signaling, NF-kB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117: 563-574.
22. Herold T, Jurinovic V, MulawM, Seiler T, Dufour A, Schneider S, Kakadia PM, Feuring-Buske M, Braess J, Spiekermann K, et al. 2011. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20. Genes Chromosomes Cancer 50: 546-558.
23. Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
24. Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J. 2005. Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res 110: 462-467.
25. Kapp AV, Tibshirani R. 2007. Are clusters found in one dataset present in another dataset? Biostatistics 8: 9-31.
26. Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, et al. 2001. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 194: 1625-1638.
27. Knowles DG, Roder M, Merkel A, Guigo R. 2013. Grape RNA-Seq analysis pipeline environment. Bioinformatics 29: 614-621.
28. Kulis M, Heath S, Bibikova M, Queiros AC, Navarro A, Clot G, Martinez-Trillos A, Castellano G, Brun-Heath I, Pinyol M, et al. 2012. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 44: 1236-1242.
29. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, Sato M,Wang K, Sumazin P, Kustagi M, Bisikirska BC, et al. 2010. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol 6: 377.
30. Li FJ, Ding S, Pan J, Shakhmatov MA, Kashentseva E, Wu J, Li Y, Soong SJ, Chiorazzi N, Davis RS. 2008. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112: 179-187.
31. Maher C, Palanisamy N, Brenner J, Cao X, Kalyana-Sundaram S, Luo S, Khrebtukova I, Barrette T, Grasso C, Yu J, et al. 2009. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci 106: 12353-12358.
32. Marco-Sola S, Sammeth M, Guigó R, Ribeca P. 2012. The GEM mapper: Fast, accurate and versatile alignment by filtration. Nat Methods 9: 1185-1188
33. McCall MN, Irizarry RA. 2011. Thawing frozen Robust Multi-array Analysis (fRMA). BMC Bioinformatics 12: 369.
34. Mihailovich M, Militti C, Gabaldon T, Gebauer F. 2010. Eukaryotic cold shock domain proteins: Highly versatile regulators of gene expression. Bioessays 32: 109-118.
35. Mitelman F, Johansson B,Mertens F. 2007. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7: 233-245.
36. Montgomery SB, Sammeth M, Gutierrez-ArcelusM, Lach RP, Ingle C,Nisbett J, Guigo R, Dermitzakis ET. 2010. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464: 773-777.
37. Monti S, Tamayo P, Mesirov J, Golub T. 2003. Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data. Mach Learn 52: 91-118.
38. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
39. Oscier D, Rose-Zerilli M, Winkelmann N, Gonzalez de Castro D, Gomez B, Forster J, Parker H, Parker A, Gardiner A, Collins A, et al. 2012. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 121: 468-475.
40. Pajares M, Ezponda T, Catena R, Calvo A, Pio R, Montuenga L. 2007. Alternative splicing: An emerging topic in molecular and clinical oncology. Lancet Oncol 8: 349-357.
41. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, et al. 2011. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365: 1384-1395.
42. Perez-Llamas C, Lopez-Bigas N. 2011. Gitools: Analysis and visualisation of genomic data using interactive heat-maps. PLoS ONE 6: e19541.
43. Peto R, Pike MC. 1973. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics 29: 579-584.
44. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. 2010. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: 1033-1038.
45. Prinos P, Garneau D, Lucier JF, Gendron D, Couture S, Boivin M, Brosseau JP, Lapointe E, Thibault P, Durand M, et al. 2011. Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol 18: 673-679.
46. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N, Escaramis G, Jares P, Bea S, Gonzalez-DiazM, et al. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475: 101-105.
47. Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bassaganyas L, Ramsay AJ, Bea S, Pinyol M, Martinez-Trillos A, et al. 2011. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44: 47-52.
48. Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ,Wierda WG, Gandhi V, Burger JA. 2009. B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: Specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood 114: 1029-1037.
49. Raa DT, Derks IAM, LuijksDM, van Laar J, Monsuur H, Oldreive C, Jethwa A, Hullein J, Stankovic T, Zenz T, et al. 2012. SF3B1 mutations in CLL are equivalent to p53/ATM dysfunction and cause defective puma upregulation in response to chemotherapy. In 54th ASH Annual Meeting and Exposition, Abstract 711. American Society of Hematology, Atlanta, USA.
50. Ramsay AJ, Quesada V, Foronda M, Conde L, Martinez-Trillos A, Villamor N, Rodriguez D, Kwarciak A, Garabaya C, Gallardo M, et al. 2013. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet 45: 526-530.
51. Refaeli Y, Young RM, Turner BC, Duda J, Field KA, Bishop JM. 2008. The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol 6: e152.
52. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. 2006. GenePattern 2.0. Nat Genet 38: 500-501.
53. Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, Cui Z, Zhang J, Yi K, XuW, et al. 2012. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 22: 806-821.
54. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, et al. 2001. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194: 1639-1647.
55. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB, Gertler FB. 2011. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218.
56. Simon R, Lam A, Li MC, NganM, Menenzes S, Zhao Y. 2007. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 3: 11-17.
57. Smeenk G, Wiegant WW, Marteijn JA, Luijsterburg MS, Sroczynski N, Costelloe T, Romeijn RJ, Pastink A,Mailand N, VermeulenW, et al. 2013. Poly(ADP-ribosyl)ation links the chromatin remodeler SMARCA5/SNF2H to RNF168-dependent DNA damage signaling. J Cell Sci 126: 889-903.
58. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102: 15545-15550.
59. Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, et al. 2011. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 331: 593-596.
60. Triqueneaux G, Velten M, Franzon P, Dautry F, Jacquemin-Sablon H. 1999. RNA binding specificity of Unr, a protein with five cold shock domains. Nucleic Acids Res 27: 1926-1934.
61. Velusamy T, Palanisamy N, Kalyana-SundaramS, Sahasrabuddhe AA, Maher CA, Robinson DR, Bahler DW, Cornell TT, Wilson TE, Lim MS, et al. 2013. Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia. Proc Natl Acad Sci 110: 3035-3040.
62. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
63. Wang L, Lawrence MS,Wan Y, Stojanov P, Sougnez C, Stevenson K,Werner L, Sivachenko A, DeLuca DS, Zhang L, et al. 2011. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365: 2497-2506.
64. Wilkerson MD, Hayes DN. 2010. ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking. Bioinformatics 26: 1572-1573.
65. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, et al. 2011. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478: 64-69.
66. Zenz T, Mertens D, Kuppers R, Dohner H, Stilgenbauer S. 2009. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 10: 37-50.
67. Zhuo L, Gong J, Yang R, Sheng Y, Zhou L, Kong X, Cao K. 2009. Inhibition of proliferation and differentiation and promotion of apoptosis by cyclin L2 in mouse embryonic carcinoma P19 cells. Biochem Biophys Res Commun 390: 451-457.